用于药物发现的工业规模的示范性联邦学习
Industry-Scale Orchestrated Federated Learning for Drug Discovery
摘要:
为了将联邦学习应用于药物发现,我们在欧洲创新药物计划(IMI)项目MELLODDY(授权编号831472)的背景下开发了一个新平台,该项目由10家制药公司,学术研究实验室,大型工业公司和初创公司组成。MELLODDY平台是第一个能够创建全球药物发现联合模型的行业级平台,而无需共享各个合作伙伴的机密数据集。在每次训练迭代之后,通过以加密、安全的方式聚合所有贡献伙伴的梯度,在平台上训练联合模型。该平台部署在Amazon Web Services(AWS)多帐户架构上,在私有网络中运行Kubernetes集群。在组织上,不同合作伙伴的作用被编入平台上的不同权利和许可,并以分散的方式进行管理。MELLODDY平台产生了新的科学发现,这些发现在一篇配套论文中进行了描述。
英文摘要:
To apply federated learning to drug discovery we developed a novel platform in the context of European Innovative Medicines Initiative (IMI) project MELLODDY (grant n°831472), which was comprised of 10 pharmaceutical companies, academic research labs, large industrial companies and startups. The MELLODDY platform was the first industry-scale platform to enable the creation of a global federated model for drug discovery without sharing the confidential data sets of the individual partners. The federated model was trained on the platform by aggregating the gradients of all contributing partners in a cryptographic, secure way following each training iteration. The platform was deployed on an Amazon Web Services (AWS) multi-account architecture running Kubernetes clusters in private subnets. Organisationally, the roles of the different partners were codified as different rights and permissions on the platform and administrated in a decentralized way. The MELLODDY platform generated new scientific discoveries which are described in a companion paper.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。